ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The potential mechanism of Fructus Ligustri Lucidi promoting osteogenetic differentiation of bone marrow mesenchymal stem cells based on network pharmacology, molecular docking and experimental identification

Kong, Yuanhang; Ma, Xinnan; Zhang, Xin; Wu, Leilei; Chen, Dechun; Su, Bo; Liu, Daqian; Wang, Xintao*哈尔滨医科大学
Bioengineered2022-4-1DOI: 10.1080/21655979.2022.2065753
5被引10阅读
引用收藏
分享

摘要

Recent studies have shown that the differentiation of bone marrow mesenchymal stem cells (BMSCs) into osteogenic lineages can promotes bone formation and maintains bone homeostasis, which has become a promising therapeutic strategy for skeletal diseases such as osteoporosis. Fructus Ligustri Lucidi (FLL) has been widely used for the treatment of osteoporosis and other orthopedic diseases for thousands of years. However, whether FLL plays an anti-osteoporosis role in promoting the osteogenic differentiation of BMSCs, as well as its active components, targets, and specific molecular mechanisms, has not been fully elucidated. First, we obtained 13 active ingredients of FLL from the Traditional Chinese Medicine Systems Pharmacology (TCSMP) database, and four active ingredients without any target were excluded. Subsequently, 102 common drug-disease targets were subjected to protein-protein interaction (PPI) analysis, Gene Oncology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The results of the three analyses were highly consistent, indicating that FLL promoted the osteogenic differentiation of BMSCs by activating the PI3K/AKT signaling pathway. Finally, we validated previous predictions using in vitro experiments, such as alkaline phosphatase (ALP) staining, alizarin red staining (ARS), and western blot analysis of osteogenic-related proteins. The organic combination of network pharmacological predictions with in vitro experimental validation comprehensively confirmed the reliability of FLL in promoting osteogenic differentiation of BMSCs. This study provides a strong theoretical support for the specific molecular mechanism and clinical application of FLL in the treatment of bone formation deficiency.

学科与关键词

关键词
Fructus Ligustri Luciditraditional Chinese medicinebone marrow mesenchymal stem cellsosteogenic differentiationPI3KAKT signaling pathwaynetwork pharmacology
相关
加载中…
  • Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
    Liang, Guihong; Zhao, Jinlong; Dou, Yaoxing; Yang, Yuan; Zhao, Di; Zhou, Zhanpeng; Zhang, Rui; Yang, Weiyi*; Zeng, Lingfeng*Frontiers in Endocrinology, 2022, 13: 866641.被引 9
  • Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs
    Liang, Guihong; Zhao, Jinlong; Pan, Jianke; Yang, Yuan; Dou, Yaoxing; Yang, Weiyi; Zeng, Lingfeng*; Liu, Jun*Journal of Orthopaedic Surgery and Research, 2023, 18(1): 312.被引 1
  • Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway
    Zhao, Jinlong; Liang, Guihong; Yang, Junzheng; Huang, Hetao; Dou, Yaoxing; Gu, Zhuoxu; Liu, Jun; Zeng, Lingfeng*; Yang, Weiyi*Pharmaceuticals, 2024, 17(1): 99.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioengineered
发表日期
2022-04-01
卷期
第 13 卷, 第 4 期
页码
10640-10653
DOI
10.1080/21655979.2022.2065753
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81772362]; Excellent Youth Foundation of Heilongjiang Province of China [JQ2020H003]

作者

  • K

    Kong, Yuanhang (第一作者)

    2 · harbin med univ

  • M

    Ma, Xinnan

    2 · harbin med univ

查看全部 8 位作者收起作者
  • Z

    Zhang, Xin

    2 · harbin med univ

  • W

    Wu, Leilei

    2 · harbin med univ

  • C

    Chen, Dechun

    2 · harbin med univ

  • S

    Su, Bo

    2 · harbin med univ

  • L

    Liu, Daqian

    2 · harbin med univ

  • W

    Wang, Xintao (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417